Key facts
- This page summarizes Steven Girgenti's Form 4 filing for bioAffinity Technologies, Inc. (BIAF).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Apr 2024, 16:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Tax liability
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
Represents shares withheld to cover the exercise price of the options exercised.
Footnote F2
These shares are owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Footnote F3
This option vested in 7 equal monthly installments beginning on April 28, 2014.